News

Deal Announcements

Heat Biologics Adds Venture Capital Debt Round

Friday, December 14, 2012 5:59:00 AM PDT | VentureDeal

   Research Triangle Park, North Carolina  --  Biotechnology company Heat Biologics has secured an undisclosed amount of venture capital debt funding.

Heat Biologics is developing a platform that provides a novel approach to treating cancer by using live, modified cell lines to activate the immune system against the cancer.

Square 1 Bank made the loan.

The company said it would use the proceeds to support its ongoing clinical trials and company growth initiatives.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.